Superworth

West Pharmaceutical Services forward PE WST

Share price divided by analysts' consensus earnings for the next twelve months, since 1994.

Today, Nov 3, 2026
44.2×
10-year median
41.7×
Against its 10-year history
57th
percentile: 0 is its lowest day, 100 its highest
10-year range
28.6× to 65.1×
Peer median
18.4×

West Pharmaceutical Services' forward PE is 44.2× as of Nov 3, 2026.

That is above its ten-year median of 41.7×, close to the middle of its last ten years.

Over that time it ranged from 28.6× in Mar 2026 to 65.1× in Feb 2024.

The median for 10 medical instruments and supplies stocks of a similar size is 18.4×.

Forward PE over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far43.9×28.6×44.4×
202535.2×30.7×56.2×
202454.3×47.8×65.1×
202355.9×34.1×61.3×
202234.5×31.6×53.3×
202156.1×38.1×57.7×
202046.5×33.9×56.4×
201943.8×35.1×47.4×
201834.4×31.4×45.2×
201738.5×33.6×40.4×
201636.9×27.1×36.9×
201529.8×28.5×34.9×
201432.3×23.8×32.7×
201329.5×19.8×30.1×
201219.5×17.1×21.7×
201117.1×16.0×19.6×
201017.3×14.6×22.4×
200919.2×15.2×20.1×
200819.3×16.7×27.8×
200718.4×16.9×24.4×

Against its peers

Companies in Medical - Instruments & Supplies nearest West Pharmaceutical Services' size, closest first, today.

CompanyForward PE
WSTWest Pharmaceutical Services44.2×
RMDResMed18.4×
MDLNMedline22.7×
BDXBecton, Dickinson and15.0×
SOLVSolventumn/m
PENPenumbran/m
COOCooper Companiesn/m
ALGNAlign Technologyn/m
GMEDGlobus Medicaln/m
PODDInsuletn/m
MSAMSA Safetyn/m
Peer median18.4×

Where West Pharmaceutical Services ranks

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on West Pharmaceutical Services

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.